国内TAVR赛道近况更新

Investment Rating - The report maintains an optimistic outlook on the TAVR market, indicating a continued growth trajectory despite a slight slowdown in growth rates compared to previous years [13][18]. Core Insights - The TAVR market in China is experiencing rapid growth, with a projected increase in the number of procedures performed, reaching 17,232 in 2024, a 14% increase from 2023 [13][14]. - Major players in the TAVR market include Peijia Medical, which has seen a significant increase in market share and revenue, and is expected to continue its growth trajectory [18][27]. - The report highlights the importance of product innovation and market expansion, with companies like Peijia Medical, HeartCare Medical, and Qiming Medical actively developing new TAVR systems to meet clinical needs [27][33]. Market Overview - The TAVR procedure is gaining traction in major provinces such as Shanghai, Sichuan, Beijing, and Guangdong, with the majority of procedures performed via the transfemoral approach [13][15]. - The report notes that the TAVR market in China has substantial room for growth, with current penetration rates being low compared to global standards [37][41]. Company Performance - Peijia Medical's revenue from TAVR procedures is projected to grow significantly, with a CAGR of 84% from 2021 to 2024, and a market share of approximately 25% in 2024 [18][19]. - HeartCare Medical has maintained stable growth, while Qiming Medical is expected to recover and regain its leading position in the market [18][27]. Competitive Landscape - The report indicates that new entrants are continuously entering the TAVR market, which is expected to enhance competition and accelerate market development [37][41]. - The introduction of centralized procurement for TAVR products is anticipated to lower costs and improve market accessibility, potentially increasing the volume of procedures performed [41][42]. Future Outlook - The TAVR market is expected to continue its growth trajectory, driven by increasing clinical adoption, product innovation, and favorable regulatory changes [10][41]. - The report emphasizes the need for companies to focus on both internal product development and external partnerships to expand their product offerings and market reach [27][33].